ABSTRACT. We studied the relationship between changes in auditory brainstem responses (ABR) and serum and cerebrospinal fluid levels of neuron-specific enolase (NSE) in hyperbilirubinemic 2-to 8-d-old piglets. Infusion of a stabilized solution of bilirubin resulted in serum bilirubin levels of 571.1 f 48.8 pmol/L (mean + SEM) after 6 h.
rubin continues to be found at autopsy in the brains of babies who died from complications of prematurity or other severe illness in the neonatal period (1 1, 12) . In some of these babies, serum bilirubin levels were never very high by the standards that ordinarily guide decisions to treat jaundice.
Furthermore, it is known that many babies who survive prematurity and/or severe illness in the neonatal period have neurologic and/or developmental sequelae (1 3-15) . Though it has been difficult in some retrospective clinical studies to demonstrate a clear relationship between neonatal jaundice and subsequent sequelae (1 6-18) , other studies are more suggestive (4, (19) (20) (21) (22) . Sick newborns are exposed to many potentially noxious influences, and it is not surprising that it should be difficult to determine the relative importance of each to the eventual outcome. Also, as the newborn brain has a considerable capacity to compensate for lost neurons, neuronal loss must be quite extensive before the sequelae would be detectable by the diagnostic methods currently at our disposal.
It is possible that the effects of bilirubin on neuronal excitability may be transitory. Such effects have been observed both in vivo and in vitro (23) (24) (25) (26) (27) . The ABR has recently been used to study jaundiced newborns, and some of these studies suggest that the changes observed during hyperbilirubinemia are reversible (23, 24, 26) . However, the mechanism for the effects of hyperbilirubinemia on the ABR has not been delineated.
The ABR is an expression of activity in a group of neurons. Apparent reversibility of neurophysiologic changes in this group of neurons does not necessarily rule out permanent damage to individual neurons. Thus, it is of interest to study whether changes in the ABR, as seen in hyperbilirubinemia, are accompanied by evidence of permanent damage to the neurons.
Enolase is one of the glycolytic enzymes and is a dimer of three subunits: a, p, and y (28). The y-subunit has been found to be identical to 14-3-2 protein, one of the nervous systemspecific proteins (29) . In the CNS, this specific protein is mainly localized in neuronal cells as a y and yy enolases, so called NSE (30) . NSE has been shown to be an indirect marker of the degree of neuronal damage in neurologic disease (3 1, 32) . Finally, it has been shown that this protein appears in the plasma and CSF of jaundiced rats (33) . The effects of bilirubin on the brain may include increased membrane permeability in the neurons (34) (35) (36) (37) . Increased permeability to small molecules such as ions, resulting in changes in the membrane potential, is likely to precede leakage of larger molecules such as proteins from the neurons. Therefore, to the extent that changes in the ABR in jaundiced, newborn piglets represent changes in membrane permeability, such changes ought to precede increases of NSE concentration in the CSF and/or serum, the latter indicating leakage of proteins from more severely compromised neurons.
NEURON-SPECIFIC ENOLASE IN BILIRUBIN ENCEPHALOPATHY

MATERIALS AND METHODS
The study protocol was approved by our institutional animal care committee. Newborn piglets (1-3 d old) were purchased from Parsons Farms, Hadley, MA, weaned from the sow, and kept in an animal care facility for 1-5 d before the study. At the time of the study, they weighed 1621 a 3 15 g (mean * SD) and were 4.5 + 2.4 d old. On the day of the study, each piglet was anesthetized with ketamine 10 mg/kg intramuscularly plus inhaled nitrous oxide (60% Nz0/40% 0 4 , supplemented with 1 % lidocaine local anesthesia. Polyethylene catheters were placed in the left femoral artery and vein and advanced into the abdominal vessels to allow for infusion and blood sampling. A 19-gauge teflon catheter was placed in the lumbar subdural space through a 17-gauge Tuohy-type epidural needle (The Kendall Company, Boston, MA) to allow repeated sampling of CSF. Subcutaneous needle electrodes were placed behind the right (active) and left (reference) ears and in the occipital (ground) area and secured with sutures, and foam rubber-padded earphones (Cadwell Insert Headphones, Cadwell Co., Kennewick, WA) were taped into both ears. A rectal probe was inserted for continuous temperature monitoring, and the output of an overhead radiant warmer was adjusted to maintain the temperature in the 38.5-39.5"C range. The piglet was placed in a dark box large enough to accommodate the animal without permitting it to turn around and allowed a 1 -h recovery period. For purposes of sedation, the piglet continued to breathe a N20/02 mixture as described above throughout the recovery period as well as the entire study period. Additional sedation was provided by diazepam 0.1-0.2 mg i.v. as required to avoid movement artifacts in the ABR.
At the start of the experiment, an ABR was obtained from the right ear using a Cadwell Quantum 84 evoked potential recordinglaveraging machine (Cadwell Laboratories, Inc., Kennewick, WA) delivering single rarified square wave clicks of 100 fis duration at 70 dB, normal hearing level, at a rate of 1 1.1 clicks/ s. Cadwell insert headphones (300 ohms), supplied by the manufacturer, were used to deliver the click signals. They had a stable output between 100 and 4000 Hz, a drive voltage of 0.49 V root mean square, peak output of 104.3 dB at 1000 Hz, and total harmonic distortion of 2.8% at 500 Hz and 118.5 dB. Low-cut and high-cut filters were set at 100 and 3000 Hz, respectively. The headphones were secured and shielded with foam rubber plugs and taped into each ear. The responses to 1000 consecutive clicks were averaged, and the peak amplitudes (fiV) and latencies (ms) of waves I-V were measured using the on-screen cursor lines, according to the criteria of Jewett and Williston (38) to define the peaks. In each tracing, vertex positivity was upward. Baseline blood samples were drawn from the femoral artery catheter, and a baseline CSF sample was obtained from the subdural catheter.
Bilirubin (Sigma Chemical Co., St. Louis, MO) was dissolved in 0.1 N NaOH, stabilized with BSA (molar ratio bilirubin:albumin = 14), and diluted with 0.055 M phosphate buffer, pH 7.4 (final pH 4). Bilirubin was then infused into the femoral vein catheter at a rate of 7 mg/kg/min for 5 min, after which the infusion was continued at 25 mg/kg/h for 6 h. Control animals were infused with bilirubin-free solvent. Sulfisoxazole 80 mg/kg (Gantrisin, Hoffman-LaRoche Inc., Nutley, NJ) was given i.v. at 0.5 and 2.5 h. The experiments were carried out under red light conditions to retard photodecomposition of the bilirubin solution. ABR and blood as well as CSF samples were obtained hourly. Serum bilirubin was measured with a diazo method (39). Serum unbound bilirubin was estimated with the peroxidase method (40) . Serum albumin was measured with the bromocresol green method (41) . NSE was measured with a RIA (Pharmacia, Uppsala, Sweden). Hematocrit was measured using microhematocrit tubes. Blood gases and pH were measured using a Corning 178 pH/blood gas analyzer (Ciba Corning Diagnostics Corp., Medfield, MA).
At the conclusion of the experiment, the animals were killed with a bolus injection of sodium pentobarbital. In the bilirubininfused animals, catheters were placed in both common carotid arteries, the jugular veins were opened, and the brain was flushed in situ with cold saline until the effluent from the jugular veins was clear. A piece of frontal cortex, vermis cerebelli, and four sections of the medulla (cochlear nucleus, superior olive, lateral lemniscus, and inferior colliculus) were dissected out. The bilirubin content of the brain tissue was estimated by acid chloroform extraction followed by diazotization (42) . Data were analyzed with t tests and two-way analysis of variance. However, to reduce the effect of heterogeneous variances of the ABR measurements, the changes over time in peak amplitudes and latencies were calculated as a slope (fiV/h and ms/h) using the program LINEFIT (43) . The null hypothesis of no change over time (slope = 0) was tested by calculating confidence intervals, and the null hypothesis of no difference between bilirubin-infused animals and controls was tested with unpaired t tests. Statistical significance was taken a s p < 0.05.
RESULTS
The results of the blood and serum analyses are presented in Table 1 . Unbound bilirubin is not detectable in nonjaundiced subjects and was therefore not analyzed in the control piglets. As expected, the serum albumin levels increased during the experiment because of the albumin in the infusate. For fortuitous reasons, the control piglets had lower hematocrit values than the bilirubin-infused animals. This is unlikely to have influenced the final results. The blood pH changed over time, mainly because a metabolic acidosis developed at 6 h in the bilirubin-infused piglets. The values for Pcoz and Poz did not change over time and did not differ between the groups. These data are therefore not reported.
Values for peak amplitudes and latencies of the piglet ABR, based on the baseline ABR in all study animals, are presented in Table 2 . As will be seen, it was possible to consistently record values for five peaks plus the trough after peak V. To our knowledge, this is the first time ABR values have been reported for piglets.
The results of the analyses of changes in ABR peak amplitudes are presented in Table 3 : The slopes of the changes in ABR peak amplitudes were negative for all bilirubin-infused piglets (although not significantly different from 0 for peak I), meaning that the ABR peak amplitudes were reduced with time of exposure to hyperbilirubinemia. Plotting of the data showed that the slopes were linear, and extrapolation of the slope indicated that isoelectricity would have been reached after 10 to 12 h if the same trend had continued. With the exception of peak I, there was no significant change over time in the amplitudes for the control piglets. Although the slope of the peak I amplitude changes was negative for the control piglets, there was no significant difference between the apparent changes for the control piglets and for the bilirubin-infused piglets. The biologic significance of this change is therefore not clear. For ABR peak amplitudes 11-V, the differences in slope between bilirubin-infused piglets and controls were significant.
To ascertain the time relationship for appearance of significant reductions in the ABR amplitudes, all amplitudes were recalculated as percentages of the baseline value for that particular peak and subject. The values for control and bilirubin-infused piglets were then contrasted using unpaired t tests for each time point. For peak 11, these contrasts were significant from 5 h on; for peak 111, they were significant from 3 h on; for peak IV, none of the contrasts were significant because of large variances; and for peak V, the contrasts were significant from 2 h on.
The results of the analyses of changes in ABR peak latencies are presented in Table 4 . As will be seen, there were no significant changes over time in either the bilirubin-infused piglets or the controls, and there were no significant differences between the groups. However, the slopes for all latencies except trough were 526 HANSEN ET AL. positive, indicating a slight increase in latencies over time. The data were therefore recalculated as percentages of baseline value and reanalyzed using analysis of variance. There were no significant group, time, or group-by-time interaction effects. The 1-11, 1-111, I-IV, I-V, and I-trough interwave intervals were measured, recalculated as percentages of baseline value, and analyzed using analysis of variance. There were no significant group, time, or group-by-time interaction effects. Examples of piglet ABR tracings illustrating the changes between 0 and 6 h during hyperbilirubinemia are shown in Figure I . * B, bilirubin-infused (n = 7); C, controls ( n = 6). Results are presented as mean f SEM $ All p values are two-tailed. The results of brain bilirubin extractions from medulla, cerebral cortex, and vermis cerebelli are shown in Table 5 . Though it appeared that tissue bilirubin concentrations were higher in the medulla, these differences were not significant. In cats, peak I in the ABR is thought to have its anatomical correlate in the auditory nerve, peak I1 in the cochlear nucleus, peak I11 in the superior olive, peak IV in the lateral lemniscus, and peak V in the inferior colliculus (44) . Data are not known for piglets, and correlation analyses of cochlear nucleus bilirubin concentration with peak I1 amplitude at 6 h, superior olive bilirubin concentrations with peak I11 amplitude at 6 h, lateral lemniscus bilirubin concentrations with peak IV amplitude at 6 h, and inferior colliculus bilirubin concentrations with peak V amplitude at 6 h did not yield any significant correlations (data not presented). Further studies are needed to I ) ascertain the anatomical correlates of the various ABR peaks in piglets, and 2) determine the relationship, if any, between brain bilirubin levels and amplitude reductions.
Finally, the results of the analyses of serum and CSF NSE are presented in Table 6 . Normal levels of serum and CSF NSE are not known in piglets, but the levels of serum NSE remained within what is thought to be a normal range for healthy humans throughout the duration of the experiment and did not change significantly over time, nor did they differ between the groups. The levels of NSE in CSF were somewhat higher, but generally within what appears to be a normal range for rats (<I7 Fg/L) (45) . For reasons that appear fortuitous, the CSF NSE levels were significantly higher in the controls than in the bilirubin-infused piglets.
DISCUSSION
Our results show that hyperbilirubinemia decreases peak amplitudes in the piglet ABR. Similar effects of hyperbilirubinemia on the ABR have been demonstrated in rats (46) , but Shapiro (47) also observed increased latencies for waves I1 and 111, as well as increased 1-11 and 1-111 interwave intervals. In human neonates, as well as in rhesus monkeys, both reduction of amplitudes and prolongation of latencies have been observed (23) (24) (25) (48) (49) (50) . Our results provide additional evidence that bilirubin in the brain influences neuronal function, and this effect occurs in several species. The newborn piglet appears to be a useful model for bilirubin neurotoxicity in the newborn period.
It is not clear whether bilirubin-induced effects on the ABR are due to changes in neuronal permeability or to inhibition of synaptic function by other mechanisms, such as neurotransmitter release. There is experimental evidence to suggest that bilirubin effects on neurons, at least in vitro, may include both increased membrane permeability (34-37) and inhibition of the biochemical mechanisms underlying neurotransmitter release ( 5 1). The lack of increase of NSE concentrations in serum and CSF in the present study is compatible with both of these mechanisms. If increased membrane permeability is indeed the mechanism underlying bilirubin effects on the ABR, the findings presented herein support our hypothesis that ABR changes would appear before the concentration of NSE in serum and/or CSF began to increase. On the other hand, if hyperbilirubinemia affects the ABR through the neurotransmitter release process rather than by increasing membrane permeability, NSE concentrations in serum and/or CSF might not increase at all. Regardless of the mechanism involved, the results reported here are compatible with clinical impressions of reversibility of ABR changes in jaundiced newborns.
The increases in NSE detected in homozygous Gunn rats by Semba and Kato (33) were primarily seen in rats with severe kernicterus induced by the injection of a displacing agent (bucolome) 16-18 h before they were killed. In these, CSF NSE levels (45) found NSE levels of =I00 pg/L in rat CSF 6 h after injecting kainic acid in the striatum. The experiments reported herein used much higher serum bilirubin concentrations than those found in homozygous Gunn rats, as well as repeated injections of a displacing substance, resulting in higher brain bilirubin concentrations than one might expect to find in homozygous Gunn rats. Whether the insult caused by this type of manipulation equates to that of a more prolonged but less intense hyperbilirubinemia typically seen in jaundiced neonates needs to be studied further. The fact that some studies have reported effects on amplitudes, others primarily on latencies, and some on both, is another indication of the need for further studies in this area.
Thus, the studies reported herein showed that hyperbilirubinemia in piglets resulted in significant reductions in ABR peak amplitudes (~5 0 % reduction after 6 h), without increases in serum or CSF NSE concentrations. This suggests that changes in the ABR may occur without severe compromise of neuronal membrane integrity and provides further support to the idea that early ABR changes during hyperbilirubinemia may be reversible.
